DU

Delphia (USA) Portfolio holdings

AUM $445K
This Quarter Return
+9.12%
1 Year Return
+28.83%
3 Year Return
5 Year Return
10 Year Return
AUM
$94.1M
AUM Growth
Cap. Flow
+$94.1M
Cap. Flow %
100%
Top 10 Hldgs %
16.04%
Holding
264
New
264
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Technology 20.72%
2 Healthcare 15.9%
3 Consumer Discretionary 12.95%
4 Communication Services 8.88%
5 Industrials 8.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VVNT
251
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$105K 0.11%
+10,785
New +$105K
RYAM icon
252
Rayonier Advanced Materials
RYAM
$373M
$104K 0.11%
+18,215
New +$104K
DSKE
253
DELISTED
Daseke, Inc. Common Stock
DSKE
$101K 0.11%
+10,031
New +$101K
PBI icon
254
Pitney Bowes
PBI
$2.09B
$100K 0.11%
+15,042
New +$100K
CRD.A icon
255
Crawford & Co Class A
CRD.A
$538M
$97K 0.1%
+13,003
New +$97K
MRC icon
256
MRC Global
MRC
$1.28B
$88K 0.09%
+12,834
New +$88K
RLGT icon
257
Radiant Logistics
RLGT
$305M
$78K 0.08%
+10,664
New +$78K
SXC icon
258
SunCoke Energy
SXC
$654M
$72K 0.08%
+10,990
New +$72K
DNTH icon
259
Dianthus Therapeutics
DNTH
$759M
$68K 0.07%
+15,398
New +$68K
MTEM
260
DELISTED
Molecular Templates, Inc.
MTEM
$67K 0.07%
+17,078
New +$67K
CGEN icon
261
Compugen
CGEN
$132M
$64K 0.07%
+14,791
New +$64K
VKTX icon
262
Viking Therapeutics
VKTX
$3.04B
$62K 0.07%
+13,468
New +$62K
SYRE icon
263
Spyre Therapeutics
SYRE
$996M
$61K 0.06%
+12,944
New +$61K
FBRX icon
264
Forte Biosciences
FBRX
$137M
$33K 0.04%
+15,256
New +$33K